Literature DB >> 15924143

Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells.

Ian M Catlett1, Stephen M Hedrick.   

Abstract

Suppressor of cytokine signaling 1 (Socs1) is critical for the regulation of interferon-gamma responses and T cell homeostasis. Although the presentation of the inflammatory disease of Socs1-deficient mice is complex, we have tested here the hypothesis that it originates from inappropriate T cell development and the appearance of autoreactive T cells. Socs1-deficient T cell receptor-transgenic mice showed severely impaired positive selection and a substantial alteration in CD4-CD8 T cell fate specification. These defects were dependent on interferon-gamma. Moreover, negative selection was also impaired, suggesting that autoimmunity contributes to the disease observed in Socs1(-/-) mice. We conclude that the constitutive expression of Socs1 in the thymus protects the process of thymic development and selection from the effects of systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924143     DOI: 10.1038/ni1211

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  19 in total

1.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

2.  Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.

Authors:  Sue J Sohn; Gavin M Lewis; Astar Winoto
Journal:  EMBO J       Date:  2008-06-12       Impact factor: 11.598

Review 3.  Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice.

Authors:  Alfred Singer; Stanley Adoro; Jung-Hyun Park
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 4.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

5.  Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.

Authors:  Kristan D Guenterberg; Gregory B Lesinski; Bethany L Mundy-Bosse; Volodymyr I Karpa; Alena Cristina Jaime-Ramirez; Lai Wei; William E Carson
Journal:  Cancer Immunol Immunother       Date:  2011-05-21       Impact factor: 6.968

6.  Decreased SOCS1 mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus in a Chinese population.

Authors:  Li-Juan Qiu; Ke Xu; Yan Liang; Han Cen; Min Zhang; Peng-Fei Wen; Jing Ni; Wang-Dong Xu; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Exp Med       Date:  2014-10-21       Impact factor: 3.984

7.  The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Jeng-Ting Tsao; Chia-Chen Kuo; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2008-09-27       Impact factor: 3.984

8.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

Authors:  Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

Review 9.  Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

Authors:  Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2009-10-30       Impact factor: 16.687

10.  TGF-β cytokine signaling promotes CD8+ T cell development and low-affinity CD4+ T cell homeostasis by regulation of interleukin-7 receptor α expression.

Authors:  Weiming Ouyang; Soyoung A Oh; Qian Ma; Michael R Bivona; Jinfang Zhu; Ming O Li
Journal:  Immunity       Date:  2013-08-08       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.